New advances in the DMARDs therapy

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptÁltalános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.contributor.authorSaito, Mizuki
dc.contributor.departmentDE--Általános Orvostudományi Kar
dc.contributor.opponentHalasi, Barbara Dóra
dc.contributor.opponentSzentmiklósi, József
dc.contributor.opponentdeptÁltalános Orvostudományi Kar::Igazságügyi Orvostani Intézet
dc.contributor.opponentdeptÁltalános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.date.accessioned2024-04-17T11:04:04Z
dc.date.available2024-04-17T11:04:04Z
dc.date.created2023-03-09
dc.description.abstractThis thesis is about the history of medications against rheumatoid arthritis and the new DMARDs currently under development. A major turning point in the history of pharmacological treatment against rheumatoid arthritis was the development and use of methotrexate.Unlike previous symptomatic drugs, methotrexate acts directly on the pathophysiology of rheumatoid arthritis, resulting in a significant improvement in the prognosis of many patients of rheumatoid arthritis. Further developments, such as targeted DMARDs containing Jak inhibitors and biological DMARDs such as IL-6 inhibitors and anti-TNFs, have enabled patients who could not achieve remission with methotrexate alone to achieve remission. In addition, new drugs targeting completely different steps of the pathomechanism from previously developed DMARDs are currently under development. While drugs for existing and new targets are being developed, another aspect of advance is the development of biosimilars which make treatments available at a lower cost. As a conclusion, many of new DMARDs are currently under development, and it is hoped that further advances of the developments will relieve more patients from suffering from rheumatoid arthritis in the future.
dc.description.courseáltalános orvos
dc.description.courselangangol
dc.description.degreeegységes, osztatlan
dc.format.extent40
dc.identifier.urihttps://hdl.handle.net/2437/368905
dc.language.isoen
dc.rights.accessHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.
dc.subjectPharmacology
dc.subjectDMARDs
dc.subjectRheumatoid arthritis
dc.subject.dspaceMedicine
dc.titleNew advances in the DMARDs therapy
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
New advances in the DMARDs therapy.pdf
Méret:
1.42 MB
Formátum:
Adobe Portable Document Format
Leírás:
Megjelenítés
Engedélyek köteg
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
license.txt
Méret:
1.94 KB
Formátum:
Item-specific license agreed upon to submission
Leírás:
Letöltés
Gyűjtemények
Theses (Faculty of Medicine)